Echo/Doppler screening should be looked upon as a strategy used in a select population of healthy, asymptomatic individuals to identify pre-emergent disease. Using focused echo/Doppler screening the incidence of a cardiovascular finding in athletes has been reported to be roughly one case in every 170 athletes screened with a "false positive" finding in only 8 of 508 athletes [2, 10, [13] [14] [15] . We describe how to provide a highest quality, exceptionally low cost pathophysiologic athletic screening test, which is validated to differentiate the status of a normal state from an abnormal life-threatening pathophysiologic state.
Cardiomyopathies
Normal CV function can be effectively and reproducibly measured as a small set of related echo/Doppler data [30, 46, 47] Table 1 and 2. Essential screening for cardiomyopathies is not designed to define a specific disease, but should be focused on the imminent risk of sudden death. Risk is most easily and accurately defined as a weighted expression [22, 23] of a small group [16, 17, 28, 48] of linked diastolic parameters [9, 49] . The essential focused echocardiographic approach has been validated to have a very low incidence of false positive and false negative interpretations [9, 14, 48, 50] . Outliers within a disease module can be appropriately classified [48] . In most circumstances only 2 to 4 aggregated diastolic features (e', E/e' ratio, DT, E/A ratio) will suffice to differentiate normal vs. abnormal pathophysiology [51] .
Asymptomatic diastolic myocyte dysfunction followed by systolic myocyte dysfunction and microvascular ischemiaemerge early in the pathophysiologic continuum, while structuraland electrical remodeling (electrical heterogeneity, arrhythmogenesis, and fibrosis) and symptoms occur later [60] . The prognostic importance of asymptomatic pre-emergent pathophysiology has only recently been realized [61, 62] . Asymptomatic athletes commonly engage in activities that can accentuate pre-emergent pathophysiology that could be acutely detrimental to myocardial function. For screening purposes" cardiomyopathy" can theoretically apply to almost any disease affecting the heart in which the heart muscle is structurally abnormal. Essential screening should be focused on prognostication of risk ,and not detection, or characterization of a disease type [12, 63] . An essential examrequires the acquisition of a small number of essential data, which define the presence and intensity ofemergent cardiac dysfunction Table 1 . Disease risk is always defined by more than one datum feature. Hypertrophic cardiomyopathy (HCM) is an exemplary candidate for pathophysiologic screening. HCM rarely has any premonitory symptoms [35] , even under exertion [35] , ECG has a high rate of false positives [64] [65] [66] [67] , ejection fraction (EF) is rarely abnormal, [32] and anatomic remodeling is variable, and typically occurs late in the pathophysiologic cascade [68] . However, associated diastolic dysfunction can be detected and measured early in the HCM cascade [68] [69] [70] and is capable of detecting pre-clinicalHCM risk [68, 69, 71] . An essential screening exam is the one designed to affirm the existence of anormal physiologic profile, and identify individuals with an abnormal risk profile, independent of morphology Table 2 [9, 21, 28, 72] .The algebraic summation of a small aggregate of related data (E/A, DT, e', E/e')define causality [28, 41] which mirrors the status of an individual's risk state in both a positive and negative direction during serial screening, management, and follow-up [7, 8, 73] .
Cardiomyopathy-screening needs to take a focused approach to potential emergent cardiac dysfunction and risk [36, 74] . Each cardiomyopathy disease(hypertrophic [68, 75] , restrictive [76, 77] , dilated [78] , ischemic [79, 80] , hypertensive [81, 82] , arrhythmogenic right ventricular [83] , myocarditis [84] , left ventricular non-compaction [85, 86] ) each has validated pathophysiologic features that can confirm a risk state [52, 87] . Averaged features have a very low incidence of false positives and false negatives results [9, 14, 48, 50] .
Hypertensive Heart Disease
The essential pathophysiologic data used to depict the risk of hypertensive heart disease [81, 82] and "pseudo-HCM" [48, 91, 92] are identical to those of general cardiomyopathies [60] Table 1&2 . Screening blood pressure and increased LVwall thickness serve only as benchmarks that require physiologic classification as normal compensatory physiology versus emergent heart disease [91] . The overlapping features of normal [9, 54, 93] myocardial remodeling can mimic the features of HCM, hypertensive heart disease, and infiltrative diseases [81, 94] . These overlapping features have been referred to as the "gray zone". The overlapping features are not essential to an essential, focused examination attempting to determine risk. The goal of essential screening is to affirm normal and rule out abnormal disease related remodeling [5] .
Ischemic Heart Disease
Although considerable attention is focused on young athletes, the risk of sudden death from coronary artery disease (CAD) is much greater among sports participants older than 35 years • EF= Ejection Fraction [100] ). Screening stress testing [67, [101] [102] [103] and CT coronary angiography [104] are considered inadequate means of assessing CAD risk in asymptomatic adults. Coronary calcium score may be helpful to determine the burden of CAD, but at this time the risk associated with a particular calcium score is unknown [105] and deemed an inappropriate marker for those at low risk [106] . In an asymptomatic population, echocardiographic physiologic dysfunction asan indicator of asymptomatic life threatening cardiac dysfunction is often underappreciated [69] .
In asymptomatic adults, resting echo/Doppler diastolic function assessment Table 1&2 is reported to be an excellent independent predictor of imminent CAD risk [107] [108] [109] [110] [111] .
There is controversy regarding the means of quantifying imminent CAD riskin asymptomatic athletes (92) . At present, recommendations for the assessment of imminent risk are limited, inconsistent, or nonexistent [101, 108, 112] . However, echo/Doppler determination of an individual's physiologic state is a logical general predictor of imminent risk, includingthe risk of ischemic heart disease. If the physiologic risk was sufficiently abnormal further assessment ofcoronary anatomy and physiology would be clinically indicated particularly in individual's ≥35 years old. As the population ages, the incidence of pre-clinical risk associated diastolic dysfunction increases [61, 62] . This fact supports the use of essential screening in the general population just as screening is used withother disease processes (e.g., colonoscopy [113] ; mammography [114] ; and often CV disease [115] ).
Channelopathies
Channelopathies are considered unique and are variably classified asa primary electrical disease or cardiomyopathy [36, 60] . Various forms of electrical cardiomyopathy affect about 1 in 1000 people [116] .Channelopathies are the assumed culprit in cases of undefined sudden death [65] . Randomized and/or blinded studies do not exist in this field. All recommendations are based on consensus opinions [117] . An important clinical finding is that 50% of these sudden death victims have preceding "warning signs": exercise /auditory triggered fainting/ seizures, family history of premature CAD (<40 years of age), or unexplained accidents, and near drowning [116] .
Proper recognition ofthesewarning signsmay significantly reduce primary electrical deaths and initiate amore comprehensive electrophysiology workup [65, 118] . Currently technical and logistical challenges preclude the use of ECG as a robust tool for universal screening in asymptomatic population [116, 119] . One of the biggest challenges with ECG is the high incidence of false positive findings [66, 118] . Interestingly in recent research subclinical Doppler pathophysiologic changes were identified in nearly 20% of Long QT syndrome patients [120] . These findings prompt speculation that electrical dysfunction (abnormal cardiac repolarization and rhythm) may precipitate macroscopic structural and functional changes visible on focused echocardiograms [120, 121] .
Structural and Hemodynamic CardiacDisease Pulmonary Hypertension
Pulmonary artery pressure (PAP) can be estimated in nearly 100% of patients using any one of three simple techniques [122] : (1) Systolic PAP using the Tricuspid Regurgitant Velocity (TRv) (Normal TRv≤2.8 m/s corresponding to a right atrioventricular gradient ≤31 mmHg] is considered a reasonable cutoff to define elevated PAP in healthy persons; (2) Normal Diastolic PAP using the end-diastolic Pulmonary Regurgitant Velocity(PRv) (PRv <1.1 m/s corresponding to an end-diastolic pressure of <5 mmHg] is correlated with normal pulmonary pressure.; and (3) normal mean PAP using pulmonary flow acceleration time (AcT) (AcT defined as the time interval from the onset of forward flow in the PA to peak velocity of this flow). AcT >100 ms equates a mean PAP < 20-39 mmHg and AcT <75 ms equates to a mean PAP ≥40 mmHg [123, 124] Table 3 .
Coarctation of aorta
Is a rare cause of hypertension.It should be excluded in every patient with elevated blood pressure, or in the presence of a BAV [126] . Coarctation cannot be effectively detected by random blood pressure measurements or a cursory physical exam [24] , but can be detected and quantified by a simple echo/Doppler signal in the abdominal aorta [127] . In the presence of coarctation the overall aortic velocity is blunted, systolic upstroke is delayed and there is continuous forward flow consistent with a diastolic and systolic gradient and/or collateral flow. These abdominal aortic pulsed-wave Doppler signals were recorded in a normal patient (upper panel) and a patient with severe coarctation of the aorta (lower panel). The normal tracing (upper) shows a rapid systolic upstroke and return to baseline at end-systole. The early diastolic reversal of flow associated with a widely patent aortic arch. Elastic recoil of the ascending aorta causes the low velocity, late-diastolic forward flow seen after the early diastolic reversal. 
Anomalous Coronary Artery
An essential component of every athletic screening examination is the visualization of the origin of the proximal coronary arteries, which can be accomplished with transthoracic echocardiography in 70 t oover 95% of young athletes [14, 66, [128] [129] [130] .Other technologies (e.g., MR and CT) do not fit the essential qualifications of a focused screening exam principally because of limited access and cost [131] .Although the anomalous origin and course of the left or right coronary artery has been reported to be exceedingly rare in young athletes [129] , others have reported that coronary artery anomalies are the second most common association with sudden death in athletes (i.e., ≈17%) [128] . The most life-threatening anomaly is left or right coronary artery originating from the contralateral sinus of Valsalva and coursing between the aorta and proximal pulmonary artery Figure 3 [3, 132, 133] .The management of the coronary anomalies is controversial [133] . If an anomalous coronary is identified or suspected further diagnostic and clinical assessment would be indicated.
A. Echocardiogram (135) . Anomalous right coronary artery (RCA) arising from a common orifice with the left main coronary artery Computed tomography [134] . Single right coronary artery with an inter arterial path of the left main coronary stem. Left coronary artery (white arrowheads) originates for the proximal part of the right coronary artery (black arrow) then follows an inter-arterial path between the ascending aorta and the pulmonary trunk. The white arrows indicate the inter-arterial part of the circumflex coronary artery. AO: Ascending Aorta; LA: Left Atrium LV: Left Ventricle.
Echocardiogram [135] . Anomalous origin of he left anterior descending (LAD) coronary from the proximal right coronary artery (RCA).
Aortic Aneurysm
Another essential component of a focused screening CV exam is documentation of the anterior-posterior aortic diameter [e.g., leading edge to leading edge, at end-diastole [52] at the level of aortic annulus, sinuses of Valsalva, sinotubular junction, and ascending aorta. An aortic root dimension >40 mm in highly conditioned male athletes and >34 mm in female athletes is uncommon; is unlikely to represent the physiological consequences of exercise training; is most likely an expression of a pathological condition [136] ; and mandates size-based surveillance [137] Table 4 .Although there are multiple types of aortic aneurysms [137] there are three syndromic aortopathies of particular concern in asymptomatic athletes:Marfan syndrome [138, 139] ,BAV [140] [141] [142] , and cystic medial necrosis [143] . The presence of any aortic valve regurgitation in a young athlete should alert the examiner to a possible structural abnormality of the aortic valve [140] . The pathophysiology and genetics of these aneurysms are similar and should be recognized as having a life-long enhanced risk of an aortic pathology [144] . In focused screening Marfan syndrome body habitus is variable and not discriminating enough to be essential. Both Marfan syndrome and cystic medial necrosis have a characteristic sinus of Val salva aneurysm (i.e., Erlenmeyer flask configuration) [139, 143] Figure  4 . The aortopathy associated with BAV is different and is usually a fusi form ascending aortic aneurysm [140] Figure 5 . Risk of rupture of a non-syndromic aortic aneurysm is expressed as an indexed relative size (i.e., diameter indexed to body surface area) [145] [146] [147] Table 4 . However young patients particularly with a syndromic aortic aneurysm approaching 5.0 cm should be considered surgical candidate. Counseling and CV evaluation of all first-degree relatives is strongly recommended [142] .In older men who have ever smoked an abdominal aortic aneurysm (AAA) should also be ruled out [148] . A ruptured AAA is usually catastrophic. Screening in women for AAA has not been shown to provide benefit [149] .
Valve Disease
Echo/Doppleris a validated approach for evaluating both asymptomatic [150] [151] [152] and symptomatic valvular heart disease [150] .Early echocardiographic screening of valve disease in the general population does not translate into reduced risk of death or cardiovascular events [153, 154] .The essential objective of preparticipation athletic screening is early detection of imminent risk [48, 99, 155] and not a comprehensive echo anatomic and Doppler hemodynamic exam [155] . A multi-feature diastolic physiologic profile best reflects the magnitude of imminent risk Table 1&2 and guide to clinical care in patients with asymptomatic valve disease [156] . An athlete with an unremarkable history, normal physiologic profile, and mild anatomic valve disease may be eligible for physician monitored athletic activities.
Congenital Heart Disease
Congenital heart disease (CHD) is not a benign condition at any age [38] . Pathophysiologic risk assessment is usually more informative than the nuances of structural abnormalities Table  1&2 . Although there is no evidence that sudden death due to CHD in athletes and non-athletes has increased in frequency [119] . The prevalence of young and older CHD survivors now exceeds the incidence of pediatric CHD [157] . CV mortality is increased particularly in young persons with a history of CHD [38] ( median age at death 48.8 years; chronic heart failure (26%); sudden death (19%)). Athletic activity should be individualized and based on sound lifelong periodic pathophysiologic assessment. Patients with known CHD are not candidates for a focused screening exam [38, 90, 158] . It is recommended that all patients with known CHD have knowledgeable provider and a least one overreaching visit with a cardiologist with advance training and experience with CHD [158] .
Unanticipated Congenital Heart Disease in Athletes
The most important attribute of a pre-participation screening exam is not diagnosis butdetermination of imminent risk and assisted decision-making [158] . The incidental finding of CHDshould not be considered a definitive test but an alert for further evaluation. Persons performing a screening examination should have a general understanding of important normal versus suspected congenital anatomy and pathophysiology [159] .
Shunt lesions are inferred in otherwise healthy individuals by increased pulmonary blood flow, asymmetric heart chamber enlargement, arrhythmias and increased pulmonary pressure. Complex lesions are recognized by pathognomonicstructural variations. Essential anatomic landmarks include [74, 135] .
Apical 4-Chamber Internal Cardiac Crux
The internal crux is the four-quadrant intersection of the atrial and ventricular septum and septal leaflets of the mitral and tricuspid valve [160] Figure 7 . Many complex congenital anomalies will have an abnormality of the internal cardiac crux (e.g., Ebstein's Anomaly, Corrected Transposition, atrioventricular canal, etc.). Patients with irregularities of the internal cardiac crux should be referred for further CV evaluation.
The internal cardiac crux is one of the most infallible cardiac landmarks (118) . The apical 4-chamber view of the heart allows identification of the crux of the heart. The morphologic tricuspid valve consistently inserts lower on the ventricular and the morphologic mitral valve inserts higher. The internal crux anatomy unambiguously confirms the commitment of the morphologic tricuspid valve to the morphologic right ventricle. Many complex congenital anomalies distort the internal cardiac crux (Ebstein Anomaly, corrected transposition).The internal cardiac crux is one of the most infallible cardiac landmarks (118) .
(Left panel)
Normal internal cardiac crux of the heart: The morphologic tricuspid valve consistently inserts lower on the ventricular and the morphologic mitral valve inserts higher. The internal crux anatomy confirms the commitment of the morphologic tricuspid valve to the morphologic right ventricle. Many complex congenital anomalies distort the internal cardiac crux (e.g., Ebstein Anomaly, corrected transposition) (142, 293) . This patient has a complex congenital abnormality where the morphologic tricuspid valve and the morphologic right ventricle are on the left side of the heart (atrial-ventricular discordance). This patient had corrected transposition of the great arteries where the morphologic right ventricle functions under system blood pressure, which commonly leads to progressive ventricular dysfunction (morphological right ventricular failure).
Non-Cardiovascular Causes of SCD
A significant proportion of sport related SCD occurs in persons with known or previously unrecognized structural or functional cardiac abnormalities. However, more than 50% of sudden death in athletes is due to other causes [161] . The most common of these are suicide and drugs, which were responsible for 29% of all sudden deaths [161] . Approximately 5-15% of cardiac arrest victims are classified as autopsy negative lacking [12] .A pathophysiologic profile will depict general risk. The risk of heat stroke [163] , substance abuse [164] [165] [166] ,and cardiac trauma are specific to the particular situation. The risk may increase in the setting of abnormal diastolic function [167] 
